CoChat

Describing Assay Precision—Reciprocal of Variance Is Correct, Not CV Percent: Its Use Should Significantly Improve Laboratory Performance

Open access

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Describing assay error as percent coefficient of variation (CV%) fails as measurements approach zero. Results are censored if below some arbitrarily chosen lower limit of quantification (LLOQ). CV% gives incorrect weighting to data obtained by therapeutic drug monitoring, with incorrect parameter values in the resulting pharmacokinetic models, and incorrect dosage regimens for patient care. METHODS: CV% was compared with the reciprocal of the variance (1/var) of each assay measurement. This method has not been considered by the laboratory community. A simple description of assay standard deviation (SD) as a polynomial function of the assay measurement over its working range was developed, the reciprocal of the assay variance determined, and its results compared with CV%. RESULTS: CV% does not provide correct weighting of measured serum concentrations as required for optimal therapeutic drug monitoring. It does not permit optimally individualized models of the behavior of a drug in a patient, resulting in incorrect dosage regimens. The assay error polynomial described here, using 1/var, provides correct weighting of such data, all the way down to and including zero. There is no need to censor low results, and no need to set any arbitrary LLOQ. CONCLUSIONS: Reciprocal of variance is the correct measure of assay precision and should replace CV%. The information is easily stored as an assay error polynomial. The laboratory can serve the medical community better. There is no longer any need for LLOQ, a significant improvement. Regulatory agencies should implement this more informed policy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/ftd.0000000000000168

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Research works printed but not linked: 2

  1. DeGroot M Probability and Statistics 1989 403 423 Addison-Wesley Reading MA 2nd ed
  2. Seber G Wild C Nonlinear regression 1989 536 37 Wiley New York

Cited by

See all 47

Metadata

Authors
Jelliffe, R. W., Schumitzky, A., Bayard, D., Fu, X., & Neely, M.
Affiliations
  • University of Southern California (US)
  • Children's Hospital Los Angeles (US)
Corresponding author
Jelliffe, Roger W.
Venue
Therapeutic Drug Monitoring
Published
2015-06
Volume
37
Issue
3
Pages
389-394
ISSN
0163-4356 (ISSN-L)
OpenAlex
W2416580215
Cited by
47
References
12
Citations by year
2026: 2 · 2025: 9 · 2024: 9 · 2023: 2 · 2022: 8 · 2021: 5 · 2020: 2 · 2019: 7 · 2018: 1 · 2016: 1 · 2015: 1
FWCI
0.74
Type
journal article
Language
en
Open access
Locations
  • Therapeutic Drug Monitoring (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institute of General Medical Sciences (R01GM068968, GM068968)
  • National Institute of Biomedical Imaging and Bioengineering (R01EB005803, EB005803)
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (HD070996, R01HD070996)
Topics
  • Health Sciences › Health Professions › Medical Laboratory Technology › Clinical Laboratory Practices and Quality Control
  • Physical Sciences › Chemistry › Analytical Chemistry › Analytical Methods in Pharmaceuticals
  • Physical Sciences › Physics and Astronomy › Instrumentation › Scientific Measurement and Uncertainty Evaluation
Keywords
assay precision, coefficient of variation, lower limit of quantification, censored data, pharmacokinetic modeling, dosing regimen
MeSH terms
Data Accuracy, Blood Chemical Analysis, Humans, Models, Statistical, Drug Monitoring, Limit of Detection

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Describing Assay Precision—Reciprocal of Variance Is Correct, Not CV Percent: Its Use Should Significantly Improve Laboratory Performance. https://app.cochat.ai/papers/10.1097/ftd.0000000000000168
The paper
Jelliffe, R. W., Schumitzky, A., Bayard, D., Fu, X., & Neely, M. (2015). Describing Assay Precision—Reciprocal of Variance Is Correct, Not CV Percent: Its Use Should Significantly Improve Laboratory Performance. Therapeutic Drug Monitoring. https://doi.org/10.1097/ftd.0000000000000168

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.